QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sonoma-pharmaceuticals-q2-eps-032-misses-031-estimate-sales-5604m-beat-4261m-estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate...

 sonoma-pharmaceuticals-terminates-evp-and-coo-bruce-thornton-for-cause-effective-october-18-2025

On October 18, 2025, Bruce Thornton was terminated as an employee and Executive Vice President and Chief Operating Officer of t...

 sonoma-pharmaceuticals--enters-at-market-issuance-sales-agreement-with-ladenburg-to-pay-3-commission-to-ladenburg-on-share-sales

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001367083/000168316825007265/sonoma_8k.htm

 5-healthcare-stocks-on-fire-this-week

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech &...

Core News & Articles

WULF: 24% | TeraWulf shares are trading higher after the company announced it signed over 200 MW in 10-year AI hosting agreemen...

 sonoma-pharmaceuticals-launches-hocl-based-diaper-rash-product-in-3600-walmart-stores-and-online

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...

 sonoma-pharmaceuticals-q4-eps-048-beats-073-estimate-sales-375m-miss-444m-estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION